CRINETICS PHARMACEUTICALS INC. - COMMON STOCK

Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 янв 2025 17:15:15 Источник Nasdaq GlobeNewswire

Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)

10 янв 2025 07:00:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

06 янв 2025 08:00:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer

16 дек 2024 08:00:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces December 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 дек 2024 20:44:38 Источник Nasdaq GlobeNewswire

Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly

09 дек 2024 08:00:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences

15 ноя 2024 09:00:00 Источник Nasdaq GlobeNewswire

UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting

14 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting

12 ноя 2024 16:07:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

12 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces November 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 12, 2024

16 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 окт 2024 16:40:28 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

08 окт 2024 23:55:11 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

08 окт 2024 16:01:51 Источник Nasdaq GlobeNewswire

Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly

26 сен 2024 16:05:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 сен 2024 16:40:25 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences

29 авг 2024 16:05:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12 авг 2024 16:05:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

08 авг 2024 16:05:01 Источник Nasdaq GlobeNewswire